Olympus shares plunge after its CEO resigns over alleged illegal drug purchases
Briefly

Stefan Kaufmann, CEO of Olympus, has resigned after allegations of purchasing illegal drugs, causing the company's shares to drop 6%.
The board, upon confirming inappropriate conduct, decided Käufmann's actions were inconsistent with Olympus' global code of conduct, leading to his resignation.
Olympus has shifted focus from its long-standing camera division to medical equipment since 2020, successfully commanding a major share of the endoscope market.
While Olympus searches for a new CEO, Yasuo Takeuchi will temporarily assume the CEO position as the company evaluates its options.
Read at Fortune Asia
[
|
]